Stock NIDL EIKO LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Eiko LifeSciences Limited

Equities

NIDL

INE666Q01016

Delayed Bombay S.E.
Other stock markets
 04:04:41 2024-06-27 EDT 		5-day change 1st Jan Change
50.49 INR +1.57% Intraday chart for Eiko LifeSciences Limited +0.32% -21.95%
05-31 Eiko Lifesciences Forms New Limited Liability Partnership MT
05-13 Eiko LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Eiko Lifesciences Forms New Limited Liability Partnership
MT
Eiko LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Eiko LifeSciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Eiko Lifesciences Completes Acquisition of 25% Stake in Reflux Pharmaceuticals
MT
Eiko LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Eiko Lifesciences Limited Enters into Definitive Business Agreement with Vivacious Pharmatex Private Limited
CI
Eiko Lifesciences Limited Approves Appointment of Company Secretary and Compliance Officer
CI
Eiko LifeSciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Eiko Lifesciences Limited Announces Resignation of Nilima Burghate as Company Secretary and Compliance Officer
CI
Eiko LifeSciences Limited Approves Appointment of Nilima A. Burghate as Company Secretary and Compliance Officer
CI
Eiko LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Eiko LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Eiko Lifesciences Limited Announces Resignation of Avi Vijaykumar Mundecha as Company Secretary and Compliance Officer
CI
Eiko Lifesciences to Acquire Minority Stake in Reflux Pharmaceuticals
MT
Eiko LifeSciences Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Eiko LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
CI
Eiko Lifesciences Completes Acquisition of Minority Stake in Vivacious Pharmatex
MT
Eiko LifeSciences Limited completed the acquisition of 5% interest in Vivacious Pharmatex Private Limited from existing shareholders cum Directors.
CI
Eiko Lifesciences to Acquire Minority Stake in Vivacious Pharmatex
MT
Eiko LifeSciences Limited signed the Memorandum of Understanding cum Share Purchase Agreement to acquire 5% interest in Vivacious Pharmatex Private Limited from existing shareholders cum Directors for INR 0.51 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NIDL Stock
  4. News Eiko LifeSciences Limited